{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:26Z","timestamp":1792801946846,"version":"4.5.0"},"reference-count":327,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Jilin Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013284","name":"Program for Jilin University Science and Technology Innovative Research Team","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013284","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015217","name":"National Key Laboratory of Aerodynamic Design and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117897","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:42:32Z","timestamp":1738928552000},"page":"117897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines"],"prefix":"10.1016","volume":"184","author":[{"given":"Yuanyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-3331","authenticated-orcid":false,"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117897_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib2","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6","author":"Nguyen","year":"2021","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.biopha.2025.117897_bib5","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1039\/D2CS00647B","article-title":"Materials engineering strategies for cancer vaccine adjuvant development","volume":"52","author":"Zhang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41551-019-0503-3","article-title":"A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia","volume":"4","author":"Shah","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.117897_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib9","article-title":"In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biopha.2025.117897_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","article-title":"Eliciting B cell immunity against infectious diseases using nanovaccines","volume":"16","author":"Singh","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122345","article-title":"Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines","volume":"303","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1021\/acsnano.7b00978","article-title":"Efficient Nanovaccine Delivery in Cancer Immunotherapy","volume":"11","author":"Zhu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jconrel.2023.02.015","article-title":"Vaccine-like nanomedicine for cancer immunotherapy","volume":"355","author":"Yi","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2326-6066.CIR-19-0545","article-title":"Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma","volume":"8","author":"Pavlick","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2025.117897_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for established cancer: overcoming the challenges posed by immune evasion","volume":"16","author":"van der Burg","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8100095","article-title":"Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites","volume":"8","author":"Tomai\u0107","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.117897_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumour-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.004","article-title":"Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors","volume":"183","author":"Roudko","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Sci. (N. Y., NY)"},{"key":"10.1016\/j.biopha.2025.117897_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.117897_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"565","author":"Hilf","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41563-018-0028-2","article-title":"A facile approach to enhance antigen response for personalized cancer vaccination","volume":"17","author":"Li","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib27","doi-asserted-by":"crossref","first-page":"18114","DOI":"10.1021\/acsnano.3c04887","article-title":"Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen Loading","volume":"17","author":"Zeng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41401-020-0417-3","article-title":"Nanoengineered targeting strategy for cancer immunotherapy","volume":"41","author":"Yin","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2025.117897_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-immunol-101721-040259","article-title":"Biomaterials-Mediated Engineering of the Immune System","volume":"41","author":"Backlund","year":"2023","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2017-04-780155","article-title":"Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia","volume":"130","author":"Anguille","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117897_bib31","article-title":"Uplifting Anti-tumor Immunotherapy with Lymph Node-targeted and Ratio-controlled Co-delivery of Tumor Cell Lysate and Adjuvant","author":"Cui","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","article-title":"Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine","volume":"113","author":"Shi","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800837","article-title":"Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy","volume":"8","author":"Hu","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib34","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1007\/s12274-018-2124-7","article-title":"Polymer nanoparticles as adjuvants in cancer immunotherapy","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.biopha.2025.117897_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113250","article-title":"Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine","volume":"152","author":"Xia","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.117897_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114107","article-title":"Nanovaccines with cell-derived components for cancer immunotherapy","volume":"182","author":"Meng","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib37","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1021\/acs.nanolett.1c03004","article-title":"Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy","volume":"21","author":"Xiong","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101098","article-title":"Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance","volume":"75","author":"Xu","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2025.117897_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101007","article-title":"Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2025.117897_bib42","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1016\/j.ymthe.2023.10.021","article-title":"Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121722","article-title":"Biomineralized hydrogel DC vaccine for cancer immunotherapy: A boosting strategy via improving immunogenicity and reversing immune-inhibitory microenvironment","volume":"288","author":"Huo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib44","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/acs.nanolett.8b01406","article-title":"Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity","volume":"18","author":"Yang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib47","article-title":"Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell\/tissue Lysate or Whole Tumor Cell","volume":"10","author":"Diao","year":"2023","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib48","article-title":"Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells","volume":"33","author":"Ma","year":"2021","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","article-title":"Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response","volume":"57","author":"Zhao","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2025.117897_bib50","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/s41467-022-31579-8","article-title":"An in situ hydrogel-mediated chemo-immunometabolic cancer therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib51","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1158\/0008-5472.CAN-15-2644","article-title":"In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments","volume":"76","author":"Morris","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.117897_bib52","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/IJN.S249174","article-title":"Superior Antitumor Efficacy of IFN-\u03b12b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.117897_bib53","article-title":"Antigen-Capturing Dendritic-Cell-Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal-Therapy-Induced In Situ Vaccination","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib54","article-title":"Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy","volume":"18","author":"Li","year":"2022","journal-title":"Small (Weinh. Der Bergstr., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib55","article-title":"NIR-Triggered Phototherapy and Immunotherapy via an Antigen-Capturing Nanoplatform for Metastatic Cancer Treatment","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib56","article-title":"Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biopha.2025.117897_bib57","article-title":"In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biopha.2025.117897_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121297","article-title":"Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines","volume":"280","author":"Viswanath","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib59","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","article-title":"Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel","volume":"4","author":"Wang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.117897_bib60","article-title":"Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2016.09.007","article-title":"Bioengineered and biohybrid bacteria-based systems for drug delivery","volume":"106","author":"Hosseinidoust","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","article-title":"Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.117897_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41551-021-00839-1","article-title":"Bacterial couriers as cancer vaccines","volume":"6","author":"Redenti","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.117897_bib64","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib65","article-title":"NIR-Triggered Phototherapy and Immunotherapy via an Antigen-Capturing Nanoplatform for Metastatic Cancer Treatment","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib66","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2020.09.038","article-title":"Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities","volume":"29","author":"Shemesh","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/admi.201701254","article-title":"Mussel-Inspired Polymer-Based Universal Spray Coating for Surface Modification: Fast Fabrication of Antibacterial and Superhydrophobic Surface Coatings","volume":"5","author":"Schlaich","year":"2018","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117897_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.2010.05187.x","article-title":"Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems","volume":"1197","author":"Macario","year":"2010","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib69","article-title":"Adewoye AH, McMahon L. Chaperones and disease","volume":"353","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.117897_bib70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew. Chem. -Int. Ed."},{"key":"10.1016\/j.biopha.2025.117897_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184721","article-title":"The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune Cells","volume":"13","author":"Linder","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.117897_bib72","doi-asserted-by":"crossref","unstructured":"Chen J., et al. Synergizing CXCL9 with BRD4-PROTAC Using Nanochaperone Boosts Robust T Cell-Dependent Antitumor Immune Responses for Cancer Immunotherapy. Advanced Functional Materials n\/a, 2314203. https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/adfm.202314203.","DOI":"10.1002\/adfm.202314203"},{"key":"10.1016\/j.biopha.2025.117897_bib73","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood-2021-152322","article-title":"Reprogramming Human Cancer Cells into Antigen Presentation","volume":"138","author":"Zimmermannova","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117897_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molimm.2022.05.076","article-title":"Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1","volume":"150","author":"Rosa","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4817","article-title":"Restoring tumor immunogenicity with dendritic cell reprogramming","volume":"8","author":"Zimmermannova","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib76","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-21-0502","article-title":"Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy","volume":"13","author":"Linde","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.117897_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2007.10.002","article-title":"Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat","volume":"29","author":"Fritz","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib79","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acsnano.0c07680","article-title":"A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+\u2009T Cell Epitopes","volume":"15","author":"He","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz4462","article-title":"The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency","volume":"6","author":"Hong","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117897_bib83","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acscentsci.8b00035","article-title":"Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy","volume":"4","author":"Cha","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2020.02.005","article-title":"Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy","volume":"80","author":"Gupta","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2025.117897_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122049","article-title":"Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy","volume":"10","author":"Makandar","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2025.117897_bib86","first-page":"167","article-title":"Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy","volume":"7","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202105742","article-title":"Application of Mannose-Functionalized Microgel as a Novel Vaccine Delivery Platform for Subunit Vaccines","volume":"31","author":"Pan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib88","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.7150\/thno.22056","article-title":"The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide","volume":"8","author":"Lai","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.117897_bib89","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12951-023-02106-8","article-title":"Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy","volume":"21","author":"Shi","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.117897_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib91","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/1074-7613(95)90067-5","article-title":"Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages","volume":"3","author":"Norbury","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2025.117897_bib92","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/icb.2011.20","article-title":"Macropinocytosis: an endocytic pathway for internalising large gulps","volume":"89","author":"Lim","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117897_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BCJ20210584","article-title":"Macropinocytosis: mechanisms and regulation","volume":"480","author":"Salloum","year":"2023","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.117897_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119795","article-title":"Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy","volume":"235","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib95","article-title":"Biomimetic Nanovaccines Potentiating Dendritic Cell Internalization via CXCR4-Mediated Macropinocytosis","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib96","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib97","article-title":"Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy","volume":"9","author":"Su","year":"2022","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib98","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.actbio.2022.12.066","article-title":"Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy","volume":"158","author":"Su","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.117897_bib99","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acs.nanolett.0c03646","article-title":"Ultrasound-Mediated Remotely Controlled Nanovaccine Delivery for Tumor Vaccination and Individualized Cancer Immunotherapy","volume":"21","author":"Meng","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib100","article-title":"Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis","volume":"10","author":"Sun","year":"2023","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib101","doi-asserted-by":"crossref","first-page":"30983","DOI":"10.1021\/acsami.8b09348","article-title":"Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117897_bib102","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3389\/fimmu.2018.02473","article-title":"The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes","volume":"9","author":"Cruz-Leal","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib103","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41565-021-00988-z","article-title":"A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours","volume":"16","author":"Cui","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib104","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","article-title":"Reprogramming tumour-associated macrophages to outcompete cancer cells","volume":"619","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib105","first-page":"330","article-title":"Engineering customized nanovaccines for enhanced cancer immunotherapy","volume":"36","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib106","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jconrel.2023.12.007","article-title":"Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy","volume":"365","author":"Dang","year":"2024","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib107","article-title":"Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy","volume":"12","author":"Yang","year":"2020","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2025.117897_bib108","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ccell.2021.05.016","article-title":"Innate immune cells in the tumor microenvironment","volume":"39","author":"Li","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.117897_bib110","article-title":"Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib111","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.7150\/thno.26758","article-title":"Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy","volume":"8","author":"Ou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.117897_bib112","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib113","article-title":"Therapeutic Nanovaccines Reshape the Metabolic and Immune Microenvironment for Enhancing Immunotherapy of Primary and Lymphatic Metastatic Tumors","author":"Fu","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib114","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1021\/acsnano.3c07123","article-title":"Mn2+\u2009\/CpG Oligodeoxynucleotides Codecorated Black Phosphorus Nanosheet Platform for Enhanced Antitumor Potency in Multimodal Therapy","volume":"18","author":"Ling","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib115","article-title":"Tumor Microenvironment-Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120114","article-title":"Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger","volume":"252","author":"Hu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121089","article-title":"Nanovaccine biomineralization for cancer immunotherapy: a NADPH oxidase-inspired strategy for improving antigen cross-presentation via lipid peroxidation","volume":"277","author":"Su","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120210","article-title":"Cascade of reactive oxygen species generation by polyprodrug for combinational photodynamic therapy","volume":"255","author":"Feng","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib119","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216396","article-title":"Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy","volume":"575","author":"Luo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib121","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic Targeting of the Tumor Microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2025.117897_bib122","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tibtech.2014.06.007","article-title":"Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells","volume":"32","author":"Eggermont","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib123","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1021\/acs.nanolett.7b03734","article-title":"Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation","volume":"17","author":"Hickey","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib124","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1021\/acsnano.3c10180","article-title":"Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy","volume":"18","author":"Hou","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903301","article-title":"Artificial Mini Dendritic Cells Boost T Cell\u2013Based Immunotherapy for Ovarian Cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878209","article-title":"CAR-T Cell Performance: How to Improve Their Persistence?","volume":"13","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib127","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001808","article-title":"Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib129","article-title":"A Personalized Cancer Nanovaccine that Enhances T-Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells","volume":"35","author":"Go","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A Distinct Function of Regulatory T Cells in Tissue Protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207719","article-title":"A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease","volume":"35","author":"Jung","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2018.05.018","article-title":"Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy","volume":"281","author":"Ou","year":"2018","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib133","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib134","doi-asserted-by":"crossref","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib135","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41467-024-47264-x","article-title":"Evolution of T cells in the cancer-resistant naked mole-rat","volume":"15","author":"Lin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib137","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"\u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer","volume":"19","author":"Silva-Santos","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib138","article-title":"Nanovaccine Showing Potent Immunotherapy to Tumor by Activating \u0393\u03b4T Cells","volume":"33","author":"Yang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib139","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib140","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/eji.201445209","article-title":"Activated NKT cells imprint NK-cell differentiation, functionality and education","volume":"45","author":"Riese","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib141","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/cmi.2015.115","article-title":"NKT cell subsets as key participants in liver physiology and pathology","volume":"13","author":"Bandyopadhyay","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib142","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.celrep.2018.02.058","article-title":"Bimodal CD40\/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression","volume":"22","author":"Cortesi","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.117897_bib143","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2025.117897_bib144","article-title":"Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and \u03b1-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells","author":"Verbeke","year":"2019","journal-title":"ACS Nano 13, 1655-1669"},{"key":"10.1016\/j.biopha.2025.117897_bib145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: from mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib146","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib147","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.117897_bib148","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/s41467-023-41438-9","article-title":"Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8+\u2009T cells to boost anti-PD-1 therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib149","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.117897_bib150","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib151","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","article-title":"Lymph node-targeting nanovaccines for cancer immunotherapy","volume":"351","author":"Wang","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib152","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12951-021-01146-2","article-title":"Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy","volume":"19","author":"Cai","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.117897_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: At the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib154","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/acs.accounts.0c00681","article-title":"Correction to Engineering Strategies for Lymph Node Targeted Immune Activation","volume":"53","author":"Chen","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2025.117897_bib155","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acsnano.0c02240","article-title":"Suppressing Subcapsular Sinus Macrophages Enhances Transport of Nanovaccines to Lymph Node Follicles for Robust Humoral Immunity","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib156","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biopha.2025.117897_bib157","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib158","article-title":"Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy Efficacy","volume":"7","author":"Wang","year":"2020","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib159","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1021\/acs.nanolett.9b00030","article-title":"Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+\u2009T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2025.117897_bib161","article-title":"A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines","volume":"8","author":"Hu","year":"2021","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib162","first-page":"145","article-title":"Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy","volume":"15","author":"Xia","year":"2023","journal-title":"Nanomicro Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib163","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biomaterials.2017.01.010","article-title":"Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines","volume":"122","author":"Zeng","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib164","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","article-title":"Virus entry by endocytosis","volume":"79","author":"Mercer","year":"2010","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.biopha.2025.117897_bib165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13578-024-01202-y","article-title":"Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion","volume":"14","author":"Cai","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2025.117897_bib166","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.7150\/thno.85843","article-title":"Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma","volume":"13","author":"Lin","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.117897_bib167","article-title":"Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small (Weinh. Der Bergstr., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib168","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1073\/pnas.1105200108","article-title":"In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles","volume":"108","author":"Jewell","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117897_bib169","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cncr.11462","article-title":"Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma","volume":"98","author":"Tagawa","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.08.009","article-title":"Lymph node targeting strategies to improve vaccination efficacy","volume":"267","author":"Jiang","year":"2017","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib171","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.immuni.2023.04.004","article-title":"The Spleen in Local and Systemic Regulation of Immunity","volume":"56","author":"Bronte","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2025.117897_bib172","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2025.117897_bib173","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib174","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117897_bib175","article-title":"An Immunomodulatory Zinc-Alum\/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte-Assisted Cascade Immune Activation","volume":"11","author":"Zhao","year":"2024","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib176","article-title":"Tuning the Organ Tropism of Polymersome for Spleen-Selective Nanovaccine Delivery to Boost Cancer Immunotherapy","volume":"35","author":"Gu","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib178","article-title":"Progress and challenges of mRNA vaccines","volume":"1","author":"Lin","year":"2022","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.biopha.2025.117897_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209624","article-title":"Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications","author":"Lam","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla) 35, e2209624"},{"key":"10.1016\/j.biopha.2025.117897_bib180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells","volume":"347","author":"Patel","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib181","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/nsr\/nwad214","article-title":"STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy","volume":"10","author":"Zhou","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib182","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2022.08.009","article-title":"A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs","volume":"350","author":"Bogaert","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib183","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/acs.nanolett.3c03345","article-title":"Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery","volume":"24","author":"Bogaert","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib184","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+\u2009T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117897_bib185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib186","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.biopha.2025.117897_bib187","article-title":"Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors","volume":"10","author":"Matos","year":"2023","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib188","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1021\/acsami.6b01135","article-title":"Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses","volume":"8","author":"Liu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117897_bib189","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12951-023-01832-3","article-title":"A \"trained immunity\" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.117897_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112186","article-title":"Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer","volume":"126","author":"Raval","year":"2021","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.biopha.2025.117897_bib191","article-title":"Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy","volume":"12","author":"Dutta","year":"2020","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2025.117897_bib192","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jconrel.2022.12.033","article-title":"Elastin-like polypeptide-based micelles as a promising platform in nanomedicine","volume":"353","author":"van Strien","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib193","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nano.2012.06.001","article-title":"Polymeric nanogels as vaccine delivery systems","volume":"9","author":"Ferreira","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2025.117897_bib194","article-title":"Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy","volume":"17","author":"Huang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2025.117897_bib195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc8738","article-title":"Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy","volume":"8","author":"Lei","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117897_bib196","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1021\/acsnano.3c01733","article-title":"In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy","volume":"17","author":"Ye","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib197","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cej.2015.03.075","article-title":"Synthesis of cationic chitosan hydrogel and its controlled glucose-responsive drug release behavior","volume":"273","author":"Zou","year":"2015","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2025.117897_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121619","article-title":"Hydrogel microcapsules containing engineered bacteria for sustained production and release of protein drugs","volume":"287","author":"Han","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122147","article-title":"A programmable oral bacterial hydrogel for controllable production and release of nanovaccine for tumor immunotherapy","volume":"299","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2017.02.010","article-title":"The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells","volume":"45","author":"Ramachandran","year":"2017","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2025.117897_bib201","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/acs.nanolett.0c00893","article-title":"Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib202","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1002\/anie.202106730","article-title":"In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging","volume":"60","author":"Liao","year":"2021","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"key":"10.1016\/j.biopha.2025.117897_bib203","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1021\/acsnano.1c01889","article-title":"Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors","volume":"15","author":"Sim","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib204","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ymthe.2017.08.010","article-title":"Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers","volume":"25","author":"Siegler","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib205","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1172\/JCI126199","article-title":"Endogenous T cells prevent tumor immune escape following adoptive T cell therapy","volume":"129","author":"Walsh","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.117897_bib206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.aav8692","article-title":"Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor","volume":"365","author":"Ma","year":"2019","journal-title":"Sci. (N. Y., NY)"},{"key":"10.1016\/j.biopha.2025.117897_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101280","article-title":"Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes","volume":"40","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2025.117897_bib208","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.11.021","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors","volume":"192","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib209","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2021.11.035","article-title":"Erythrocyte-enabled immunomodulation for vaccine delivery","volume":"341","author":"Wang","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib210","article-title":"Erythrocyte-Inspired Functional Materials for Biomedical Applications","volume":"10","author":"Luo","year":"2023","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib211","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7150\/thno.87425","article-title":"Red blood cells in biology and translational medicine: natural vehicle inspires new biomedical applications","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.117897_bib212","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib213","article-title":"Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy","volume":"2","author":"Wang","year":"2024","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.biopha.2025.117897_bib214","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","article-title":"Extracellular vesicles and nanoparticles: emerging complexities","volume":"33","author":"Jeppesen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2025.117897_bib215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117897_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010014","article-title":"Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics","volume":"22","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib218","article-title":"A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy","volume":"165","author":"Li","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.117897_bib219","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2025.117897_bib220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12964-023-01370-3","article-title":"Tumor immune escape: extracellular vesicles roles and therapeutics application","volume":"22","author":"Ahmadi","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2025.117897_bib221","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2025.117897_bib222","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41551-020-0584-z","article-title":"Gold\/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer","volume":"4","author":"Yang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biopha.2025.117897_bib223","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib224","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib225","article-title":"Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-022-01266-8","article-title":"Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses","volume":"15","author":"Zuo","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib227","article-title":"CCR7 Mediated Mimetic Dendritic Cell Vaccine Homing in Lymph Node for Head and Neck Squamous Cell Carcinoma Therapy","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114321","article-title":"Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy","volume":"186","author":"Long","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib229","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1038\/s41467-023-42365-5","article-title":"Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib231","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1021\/acsami.8b21820","article-title":"Photocatalysis Enhancement for Programmable Killing of Hepatocellular Carcinoma through Self-Compensation Mechanisms Based on Black Phosphorus Quantum-Dot-Hybridized Nanocatalysts","volume":"11","author":"Lan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117897_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119859","article-title":"Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen\/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold","volume":"239","author":"Nguyen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib233","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/17425247.2021.1912008","article-title":"Metallic nanoparticles as drug delivery system for the treatment of cancer","volume":"18","author":"Neha","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.117897_bib234","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12951-024-02311-z","article-title":"The quest for nanoparticle-powered vaccines in cancer immunotherapy","volume":"22","author":"Sun","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.117897_bib235","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/smll.201402179","article-title":"In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models","volume":"11","author":"Almeida","year":"2015","journal-title":"Small (Weinh. Der Bergstr., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib236","article-title":"Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak-Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib237","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1039\/D2TB01483A","article-title":"HSA-templated self-generation of gold nanoparticles for tumor vaccine delivery and combinational therapy","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2025.117897_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121808","article-title":"In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors","volume":"289","author":"Huang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib239","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00253-011-3249-8","article-title":"Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants","volume":"90","author":"Dur\u00e1n","year":"2011","journal-title":"Appl. Microbiol Biotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib240","article-title":"Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy","volume":"19","author":"Liu","year":"2023","journal-title":"Small (Weinh. Der Bergstr., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib241","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.2147\/IJN.S314308","article-title":"Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development","volume":"16","author":"de Carvalho Lima","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.117897_bib242","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/open.201900126","article-title":"Mannose-Modified Multi-Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells","volume":"8","author":"Dong","year":"2019","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.biopha.2025.117897_bib243","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2022.01.003","article-title":"Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy","volume":"342","author":"Ni","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib244","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small (Weinh. Der Bergstr., Ger. )"},{"key":"10.1016\/j.biopha.2025.117897_bib245","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib246","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2017.03.033","article-title":"Synthetic nanovaccines for immunotherapy","volume":"263","author":"Luo","year":"2017","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib247","article-title":"Multiantigenic Nanoformulations Activate Anticancer Immunity Depending on Size","volume":"29","author":"Li","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib248","article-title":"Multiantigenic Nanoformulations Activate Anticancer Immunity Depending on Size","volume":"29","author":"Li","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib249","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.2147\/IJN.S226466","article-title":"The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB\/c Mice","volume":"14","author":"Li","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.117897_bib250","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1039\/C9TB00448C","article-title":"A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization","volume":"7","author":"Wu","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2025.117897_bib251","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.117897_bib252","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1039\/C8BM00908B","article-title":"Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine","volume":"6","author":"Fan","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib253","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1039\/D2MH01358D","article-title":"Polymeric nanoparticle-based nanovaccines for cancer immunotherapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.biopha.2025.117897_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119901","article-title":"Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy","volume":"241","author":"Dai","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib255","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/acsnano.3c08792","article-title":"An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells","volume":"18","author":"Meng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib256","article-title":"A Minimalist Binary Vaccine Carrier for Personalized Postoperative Cancer Vaccine Therapy","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib257","doi-asserted-by":"crossref","first-page":"11420","DOI":"10.1021\/acs.chemrev.9b00833","article-title":"Chemical Strategies to Boost Cancer Vaccines","volume":"120","author":"Li","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib258","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","article-title":"A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists","volume":"18","author":"Baljon","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib259","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.apsb.2022.05.032","article-title":"Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.117897_bib260","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.actbio.2022.01.004","article-title":"Antigen epitope-TLR7\/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy","volume":"141","author":"Song","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.117897_bib261","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1038\/s41467-023-42155-z","article-title":"Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117897_bib262","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1021\/acsnano.3c08064","article-title":"A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma","volume":"17","author":"Tian","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib263","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1021\/acsnano.9b05974","article-title":"Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib264","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12951-022-01545-z","article-title":"Self-adjuvanting cancer nanovaccines","volume":"20","author":"Liao","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.117897_bib265","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1021\/acs.nanolett.2c04970","article-title":"Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy","volume":"23","author":"Gao","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib266","article-title":"Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib267","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jconrel.2024.04.002","article-title":"The predominant Quillaja saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine","volume":"369","author":"Zhou","year":"2024","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib268","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1021\/acsami.6b03492","article-title":"Loading Capacity versus Enzyme Activity in Anisotropic and Spherical Calcium Carbonate Microparticles","volume":"8","author":"Donatan","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2025.117897_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116520","article-title":"Preparation of lentinan-calcium carbonate microspheres and their application as vaccine adjuvants","volume":"245","author":"Liu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2025.117897_bib270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib271","doi-asserted-by":"crossref","first-page":"22146","DOI":"10.1021\/acsnano.3c10475","article-title":"Correction to \"Nanoenabled Disruption of Multiple Barriers in Antigen Cross-Presentation of Dendritic Cells via Calcium Interference for Enhanced Chemo-Immunotherapy\"","volume":"17","author":"An","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib272","doi-asserted-by":"crossref","first-page":"18758","DOI":"10.1021\/acsnano.3c02251","article-title":"An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses","volume":"17","author":"Oyama","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib273","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.117897_bib274","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block Copolymer Micelles in Nanomedicine Applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2025.117897_bib275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nmat5057","article-title":"Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination","volume":"17","author":"Xia","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib276","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat. Microbiol"},{"key":"10.1016\/j.biopha.2025.117897_bib277","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2307187","article-title":"Recent progress in mRNA cancer vaccines","volume":"20","author":"Yao","year":"2024","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.biopha.2025.117897_bib278","article-title":"Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib279","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic Cell-Based Immunotherapy: State of the Art and Beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2025.117897_bib280","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.biopha.2025.117897_bib281","doi-asserted-by":"crossref","unstructured":"mRNA Vaccine Slows Melanoma Recurrence. Cancer Discovery 13, 1278 (2023). https:\/\/doi.org\/10.1158\/2159-8290.CD-NB2023-0028.","DOI":"10.1158\/2159-8290.CD-NB2023-0028"},{"key":"10.1016\/j.biopha.2025.117897_bib282","unstructured":"Lopez J.S., et al. A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors (2020)."},{"key":"10.1016\/j.biopha.2025.117897_bib283","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib284","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib285","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.ADVBC23-PR07","article-title":"Intratumoral injection of mRNA-2752 and anti-PD-1 results in rapid regression of HER2 positive and or Hormone Receptor Negative DCIS: Phase 1 study results","volume":"84","author":"Esserman","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.117897_bib286","article-title":"A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36\u03b3, for intratumoral (iTu) injection alone and in combination with durvalumab","volume":"38","author":"Patel","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib287","doi-asserted-by":"crossref","unstructured":"Ghiaseddin A., et al. CTIM-11. MRNA AGGREGATES ELICIT RAPID IMMUNOLOGIC RESPONSE AND PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS. University of Florida, Gainesville, USA;University of Florida, Gainesville, FL, USA;Cleveland Clinic, Cleveland, USA;Children's National Hospital, Washington, DC, USA;Children's Hospital Of Philadelphia, Philadelphia, PA, USA;Un Vol.25, v63 (2023). https:\/\/doi.org\/10.1093\/neuonc\/noad179.0251.","DOI":"10.1093\/neuonc\/noad179.0251"},{"key":"10.1016\/j.biopha.2025.117897_bib288","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-0959-z","article-title":"Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"566","author":"Hilf","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib289","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1470-2045(13)70510-2","article-title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","volume":"15","author":"Butts","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib290","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1200\/jco.2008.26.15_suppl.3047","article-title":"A multicenter, open-label, phase I\/II study in patients with unresectable stage III non-small cell lung cancer (NSCLC) treated with L-BLP25: 2-year survival and safety results","volume":"26","author":"Murray","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib291","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4161\/hv.29918","article-title":"Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: an exploratory study","volume":"10","author":"Rossmann","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.biopha.2025.117897_bib292","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejca.2020.03.018","article-title":"Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)","volume":"132","author":"Singer","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib293","first-page":"3681","article-title":"Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted","volume":"8","author":"Tian","year":"2023","journal-title":"Therapy"},{"key":"10.1016\/j.biopha.2025.117897_bib294","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2025.117897_bib295","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2025.117897_bib296","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2025.117897_bib297","article-title":"Potentials of saponins-based adjuvants for nasal vaccines","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.117897_bib298","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines4040042","article-title":"The CD8\u207a T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant","volume":"4","author":"Manfredi","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2025.117897_bib299","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000410","article-title":"Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma","volume":"8","author":"Cebon","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2025.117897_bib300","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2015.02.029","article-title":"Codon optimality is a major determinant of mRNA stability","volume":"160","author":"Presnyak","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib301","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.molcel.2022.03.032","article-title":"Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability","volume":"82","author":"Bae","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.117897_bib302","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-biochem-052621-091808","article-title":"Translation and mRNA Stability Control","volume":"92","author":"Wu","year":"2023","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.biopha.2025.117897_bib303","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1093\/nar\/gkab911","article-title":"Correction to 'Theoretical basis for stabilizing messenger RNA through secondary structure design","volume":"49","author":"Wayment-Steele","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.117897_bib304","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/B978-0-323-39981-4.00021-X","article-title":"Chapter Twenty One \u2013 Regulatory Development of Nanotechnology-Based Vaccines","author":"Florindo","year":"2017","journal-title":"Micro Nanotechnol. Vaccin. Dev."},{"key":"10.1016\/j.biopha.2025.117897_bib306","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.117897_bib307","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2025.117897_bib308","article-title":"Biomimetic Nanotechnology toward Personalized Vaccines","volume":"32","author":"Zhou","year":"2020","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120709","article-title":"Nanobiomaterial-based vaccination immunotherapy of cancer","volume":"270","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib310","article-title":"Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment","author":"Zhao","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.biopha.2025.117897_bib311","article-title":"A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses","volume":"35","author":"Kuen","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.biopha.2025.117897_bib312","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jconrel.2022.03.020","article-title":"A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA","volume":"345","author":"Carson","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.117897_bib313","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biomaterials.2018.12.034","article-title":"Modularly engineered injectable hybrid hydrogels based on protein-polymer network as potent immunologic adjuvant in vivo","volume":"195","author":"Giang Phan","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib314","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1631","article-title":"Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117897_bib315","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1021\/acs.nanolett.2c00500","article-title":"Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention","volume":"22","author":"Li","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.117897_bib316","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1021\/acsnano.3c02273","article-title":"Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy","volume":"17","author":"Mao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib317","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","article-title":"Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma","volume":"9","author":"Guo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.117897_bib318","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/acs.accounts.0c00313","article-title":"Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy","volume":"53","author":"Ni","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2025.117897_bib319","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/d41586-020-02339-9","article-title":"A dendritic cell multitasks to tackle cancer","volume":"584","author":"Burbage","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117897_bib320","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00018-016-2317-8","article-title":"Molecular mechanisms involved in dendritic cell dysfunction in cancer","volume":"74","author":"Tang","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.117897_bib321","article-title":"Endogenous\/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-Mediated Tumor Immunotherapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.117897_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121528","article-title":"A peptide-AIEgen nanocomposite mediated whole cancer immunity cycle-cascade amplification for improved immunotherapy of tumor","volume":"285","author":"Dai","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.117897_bib323","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00262-020-02754-x","article-title":"PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model","volume":"70","author":"Peng","year":"2021","journal-title":"Cancer Immunol., Immunother.: CII"},{"key":"10.1016\/j.biopha.2025.117897_bib324","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1158\/1078-0432.CCR-20-0341","article-title":"Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas","volume":"26","author":"Scheetz","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2025.117897_bib325","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S2352-3026(20)30376-8","article-title":"Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?","volume":"8","author":"Gudiol","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.biopha.2025.117897_bib326","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","article-title":"Nosocomial infections in patients with cancer","volume":"10","author":"Kamboj","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.117897_bib327","article-title":"Dual-Antigen-Displaying Nanovaccines Elicit Synergistic Immunoactivation for Treating Cancer and Preventing Infectious Complications","author":"Chen","year":"2023","journal-title":"Small (Weinh. Der Bergstr., Ger. )"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:45:32Z","timestamp":1741045532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":327,"alternative-id":["S0753332225000915"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117897","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117897"}}